Results 91 to 100 of about 62,247 (257)
Undifferentiated carcinomas in a large animal model of liver cancer
Animal Models and Experimental Medicine, EarlyView.
F. Edward Boas +7 more
wiley +1 more source
Background Although some prospective clinical studies have shown comparable oncological outcomes between laparoscopic and open surgery for advanced gastric cancer, the 3-year recurrence-free survival rate of patients who undergo laparoscopic radical ...
Xiaodong Liu +16 more
doaj +1 more source
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg +9 more
wiley +1 more source
[Peritoneal metastasis of breast cancer].
By this paper we present a clinical case of a multiple abdominal metastasing, occuring after 5 years fom a right mamary neoplasm, diagnosed at c-level T2N1M0 treated multidisciplinarily, conservatively operated, sector with axilar ganglionar evidation. Histopathological type of the tumour was invasive lobular mamary carcinoma, weakly differentiated (G3)
D, Firescu +4 more
openaire +1 more source
Patients with metastatic colorectal cancer who are ineligible for upfront metastasectomy may still become candidates for secondary metastasectomy with curative intent following response to primary chemotherapy. However, most studies dichotomize metastatic colorectal cancer into resectable and unresectable disease.
Julian W. Holch +18 more
wiley +1 more source
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley +8 more
wiley +1 more source
Metastasis-associated fibroblasts in peritoneal surface malignancies
AbstractOver decades, peritoneal surface malignancies (PSMs) have been associated with limited treatment options and poor prognosis. However, advancements in perioperative systemic chemotherapy, cytoreductive surgery (CRS), and hyperthermic intraperitoneal chemotherapy (HIPEC) have significantly improved clinical outcomes.
Cristiano Ramos +2 more
openaire +2 more sources
Antiangiogenic treatment with ramucirumab is a standard second‐line option in advanced gastric and gastroesophageal junction adenocarcinoma. However, reliable biomarkers are currently lacking. This exploratory biomarker analysis of the RAMIRIS trial suggests that elevated baseline and early on‐treatment levels of the pro‐angiogenic placental growth ...
Jurek Hille +17 more
wiley +1 more source
Peritoneal metastasis of a neuroendocrine tumor of the gallbladder [PDF]
Park, Sang Hyuk, Chi, Hyun-Sook
openaire +2 more sources
Bevacizumab added to systemic chemotherapy remains a cornerstone of metastatic colorectal cancer treatment, but its effectiveness is variable. Tumors can bypass the VEGF blockade by activating other pro‐angiogenic pathways, hampering the identification of predictive biomarkers.
Büsra Akay Hacan +9 more
wiley +1 more source

